Methods for the therapeutic use of cyclosporine components
View Patent ↗Methods of treating humans or animals having rheumatoid arthritis are disclosed which include topically administering a therapeutically effective amount of a cyclosporine component to the human or animal, thereby treating the rheumatoid arthritis.
1. A method of treating rheumatoid arthritis in a human or animal, the method comprising topically administering to a human or animal having rheumatoid arthritis a therapeutically effective amount of a cyclosporin A component selected from the group consisting of cyclosporin A, salts thereof and mixtures thereof, without subjecting the remainder of the human or animal to the cyclosporin A component, thereby treating the rheumatoid arthritis.
2. The method of claim 1 wherein the topically administering step comprises topically administering the cyclosporin A component at or near a tissue area of the human or animal affected by the rheumatoid arthritis.
3. The method of claim 1 wherein the cyclosporin A component is cyclosporin A.
4. A method of treating rheumatoid arthritis in a human, the method comprising topically administering to a human having rheumatoid arthritis a therapeutically effective amount of a cyclosporin A component selected from the group consisting of cyclosporin A, salts thereof and mixtures thereof, without subjecting the remainder of the human to the cyclosporin A component, thereby treating the rheumatoid arthritis.
5. The method of claim 4 wherein the topically administering step comprises topically administering the cyclosporin A component at or near a tissue area of the human affected by the rheumatoid arthritis.
6. The method of claim 4 wherein the cyclosporin A component is cyclosporin A.